Partner

Partnering Opportunities

Screen-Printed Electrochemical Biosensors

The company is an innovative technology based company specialising in the design and manufacture of instruments for use in electrochemisty research applications; they also develop specific biosensors for a wide variety of applications. The company is based in Northern Spain. The company is looking for outsourcing or consortium collaboration with a suitable UK partner which could be a small-to-medium sized commercial company or an academic institution, either of which would specialise in electrochemical biosensor technology development.

For further information click here



Sanofi Aventis Opportunity To Support New Third Party Customers.

Sanofi-aventis has an inhalation and nasal spray manufacturing facility located in the North-West of England. This modern facility has experience of supplying metered dose aerosols, dry powder inhalers and nasal spray products to a worldwide market including USA, Europe and Japan. The site supplies sanofi-aventis products to over fifty markets worldwide and is able to consider the potential for supply to third party customers. Enquiries relating to contract manufacturing opportunities can be directed to info.holmeschapel@sanofi-aventis.com

French Imaging Product Company

The company is a French imaging company which was established in 2003. It currently has offices in France and Canada. The company operates in the Biotechnology sector, working with companies to enable them to develop market applications using the company's proprietary technology platforms.

For further information click here


South Korean Life Sciences company

The company Co Ltd, headquartered in Seoul (South Korea), has two business groups: Green Chemicals and Life Science. The Life Science Business Group, with an R&D Centre in Suwon (South Korea), manufactures and markets ethical prescription, vaccine and blood products globally. Based on the discussions between the British Embassy and The company, considerations are under way to set up an office in the UK.

For further information click here


Spanish R & D Investment Company

The company are headquartered in Spain and have presence in Latin America, USA and the Middle East.  The company is among the top 500 European companies for research and development investment.  The company specialise in IT, engineering and advanced services as well as Business Process Outsourcing.  It has developed solutions for the telecoms, energy, banking and insurance, healthcare, defence and other public administration sectors.

For further information click here


Leading specialty pharmaceutical

The company is a leading specialty pharmaceutical group in the People's Republic of China (PRC). They focus on the research and development, production and sale of natural drugs, drugs with new delivery systems and new drugs with other specific features. These products are widely used in the fields of oncology, orthopaedics, neurology, gastroenterology, cardiovascular and hepatology. The company is particularly strong in sustained-release microsphere depot injection platforms and liposome platforms. The company has built a reputation as a pharmaceutical group with strong R&D capabilities and with the expertise and ability to conduct all stage research activities for new drug development.

For further information click here

Linkedin - Join our Cluster Group

2010 Northwest Biomedical Awards Dinner - Applications now live

We are pleased to announce that the 2010 Northwest Biomedical Awards competition is open for entries. This prestigious awards dinner, celebrates key achievements from companies and individuals...

Read more

Alpha aims for UK expansion

Alpha Biolaboratories, a provider of drug, alcohol and DNA testing services, is looking to broaden its geographical reach after securing a £100,000...

Read more

Juvista® Safety Studies Following Keloid Excision Concluded Successfully

Renovo Group plc (LSE : RNVO), the biopharmaceutical company developing drugs to reduce scarring, improve wound healing and enhance tissue regeneration, today...

Read more

Technology Strategy Board launch £600k competition for disruptive solutions for energy, digital, healthcare, & sustainability problems

A competition has been just launched by TSB that includes healthcare as one of the four sectors being targeted. It is open...

Read more

Nutricia eyes global expansion

Medical nutrition company Nutricia Liverpool is aiming to expand its business into "new geographies" after investing more than €20m in its site...

Read more

Exhibit with Bionow and Medilink NW at Medica 2010 - 17-20 November

Medica 2010, Dusseldorf Medilink North West with support from Bionow (NWDA), will be returning to Medica in 2010 to assist in...

Read more

Procurement in the NHS 2010: Ensuring Value For Money - 15 September

15th September 2010: The Bridgewater Hall, Manchester Are you involved in procurement, purchasing or finance in the NHS? Are you up to date with...

Read more

Bionow Network Evening - Tuesday 14 September

Bionow will be hosting a network evening in Manchester on Tuesday 14 September at the Core Technology Facility. Further details of this event will be updated shortly.

Read more

Bionow Network Evening - Monday 13 December

Bionow will be hosting a network evening in Manchester on Monday 13 December at the Core Technology Facility. Further details of this event will be updated shortly.

Read more

7th Annual bioProcessUK Conference - Wednesday 24 - Thursday 25 November

Registration now open We are pleased to launch the 7th Annual bioProcessUK Conference. This year's conference is being held at the Midland...

Read more

Bionow Network Evening - Tuesday 15 March

Bionow will be hosting a network evening in Manchester on Tuesday 15 March at the Core Technology Facility. Further details of this event will be updated shortly.

Read more

Newsletter

To sign up for the Bionow email newsletter, please click below:

Signup

NWDA Cluster Mark